Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl
Latest NAV & returns of TATA ASSET MANAGEMENT LTD.

Tata India Pharma & Healthcare Fund Direct Rnvstmnt of Inc Dist cum Cap Wdrl

Add To Compare

previously known as Tata India Pharma & Healthcare Dir DR until

34.858 (0.466%)
NAV on January 20, 2025
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 1,287 cr
Turnover Ratio 28.44%
Expense Ratio 0.68%
Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: -1.88%
  • 1Y: 30.93%
  • 3M: -2.56%
  • 3Y: 22.41%
  • 6M: 11.87%
  • 5Y: 27.81%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Meeta Shetty (Since almost 4 years) Rajat Srivastava (Since 4 months)
ISIN INF277K011B8
Fund Family Tata
P/E Ratio 36.83
P/B Ratio 5.54
Launch Date December 28, 2015
Benchmark Nifty Pharma TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs Nifty Pharma TR INR

Alpha 3.93
Beta 0.92
R-Squared 96.84
Info Ratio 1.21
Tracking Err 3.00
Sortino 2.095
Sharpe 1.029
Std Dev 15.208
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.0%
Industrial 0.0%
Technology 0.0%
Basic Materials 2.17%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 97.83%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Dividends that would otherwise be paid out to investors are instead used to purchase more units in the fund. Not as tax efficient as Growth.

View Factsheet
-


Other plans of Tata India Pharma & Healthcare


Other Equity funds by Tata

Data Partner
Click here to visit AMC website and
read all scheme related documents Tata Fund